Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals and Epic Pharma Enter Into a Sales and Distribution Licensing Agreement for Abuse-Deterrent ELI-200
June 09, 2015 08:00 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 9, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP) announced today that it has entered into a sales and distribution licensing...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces First Shipment of Generic Isradipine Capsules
January 15, 2015 10:46 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 15, 2015 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) today announced the first shipments of generic Isradipine 2.5 mg and 5.0 mg...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015
November 18, 2014 18:24 ET | Elite Pharmaceuticals, Inc.
Revenues increase by 8% Conference Call Scheduled for Wednesday, November 19 at 11:00 AM EST NORTHVALE, N.J., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on Wednesday, November 19, 2014
November 13, 2014 17:02 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP), a specialty pharmaceutical company developing a pipeline of abuse-deterrent...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces Bridge Loan Facility
October 16, 2013 07:45 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Oct. 16, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite") (OTCBB:ELTP) announced today that it has entered into a credit line agreement ("Credit Line") with Nasrat...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces Manufacturing and License Agreement for Twelve Generic Products
October 08, 2013 07:45 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Oct. 8, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCBB:ELTP) announced today the signing of a Manufacturing and License Agreement ("Agreement")...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals Announces Participation at the 15th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th
September 03, 2013 09:46 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Sept. 3, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), today announced it will be featured as a presenting company at the 15th Annual Rodman & Renshaw Global...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2014
August 14, 2013 16:29 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 14, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral abuse-resistant...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Announces Fiscal Year 2014 First Quarter Conference Call on Thursday, August 15, 2013
August 13, 2013 11:59 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 13, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals, Inc. Hires Industry Veteran Doug Plassche as Executive Vice President of Operations
August 12, 2013 08:00 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Aug. 12, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP) today announced the appointment of industry veteran Doug Plassche as Executive Vice President of Operations...